Improving vascular health in patients with hypertension through medication and exercise

Anti-hypertensive Therapy and Exercise Treatment to Improve Vascular Health in Patients With Hypertension. A Randomized Controlled Trial.

NA · Heinrich-Heine University, Duesseldorf · NCT06823570

This study is testing whether a combination of blood pressure medication and personalized exercise can help people with high blood pressure improve their heart and blood vessel health.

Quick facts

PhaseNA
Study typeInterventional
Enrollment60 (estimated)
Ages18 Years and up
SexAll
SponsorHeinrich-Heine University, Duesseldorf (other)
Locations1 site (Düsseldorf, Düsseldorf)
Trial IDNCT06823570 on ClinicalTrials.gov

What this trial studies

This clinical trial investigates the effects of anti-hypertensive medication combined with individualized exercise training on blood pressure and vascular health in patients with hypertension. It aims to understand the mechanisms that contribute to vascular health by analyzing changes in metabolism and cell function. The study will involve 60 patients who have not previously received anti-hypertensive treatment, with regular assessments of blood pressure and vascular function over one year. The goal is to determine the effectiveness of these interventions in improving vascular health and identifying sensitive biomarkers for therapy-induced adaptations.

Who should consider this trial

Good fit: Ideal candidates are adults aged 18 and older with grade I-II systolic hypertension who are not currently on anti-hypertensive medication.

Not a fit: Patients with isolated diastolic hypertension, chronic eye diseases, or medical contraindications for exercise treatment may not benefit from this study.

Why it matters

Potential benefit: If successful, this study could lead to improved treatment strategies for hypertension, enhancing vascular health and reducing related complications.

How similar studies have performed: Previous studies have shown that exercise interventions can improve vascular dysfunction in hypertensive patients, suggesting potential success for this approach.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

\- systolic hypertension grade I-II (BP values \>140 mmHg to \<180 mmHg) without anti-hypertensive medication treatment

Exclusion Criteria:

* no written informed consent
* age \<18 years
* isolated diastolic hypertension
* medical contraindications for the exercise treatment (for example orthopedic problems or an abnormal ECG during the cardio respiratory exercise test)
* chronic eye diseases on both eyes (for example macular degeneration or glaucoma) or high intraocular pressure (\>20 mmHg)

Where this trial is running

Düsseldorf, Düsseldorf

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.

View on ClinicalTrials.gov →

Conditions: Hypertension, Vascular Function, Fitness Testing, Metabolism Changes, cardiorespiratory fitness, retinal microcirculation, endothelial function, exercise training

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.